AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLSD
  4. [8-K] Clearside Biomedical, Inc. Reports Material Event

[8-K] Clearside Biomedical, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock CLSD logo
Clearside Biomed

NASDAQ:CLSD

CLSD Rankings

#7005 Ranked by Market Cap
N/A Ranked by Dividends

CLSD Latest News

Jul 17, 2025
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
Jun 17, 2025
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
May 21, 2025
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
May 14, 2025
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 9, 2025
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

CLSD Stock Data

68.03M
67.59M
7.76%
20.11%
1.01%
Biotechnology
Pharmaceutical Preparations
United States
ALPHARETTA